时间 | 题目 | 讲者 | 单位 |
---|---|---|---|
08:00-08:10 |
Starting your academic career |
Ziv J. Haskal | University of Virginia School of Medicine, USA |
08:10-08:30 |
How to get your paper published: Tips from a 15-year editor |
Ziv J. Haskal | University of Virginia School of Medicine, USA |
08:30-08:45 |
The write path for doctors: Personal experiences and tips |
Jiaywei Tsauo | Guangdong Provincial People's Hospital, China |
08:45-09:00 |
How I mentor Chinese scholars to enhance their writing skills |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China |
09:00-09:45 |
Panel Discussion
Jian Lu
Zhongda Hospital, Southeast University, China /
Chu Hui Zeng
Asan Medical Center, KR/ Zhongda Hospital, Southeast University, China /
Bin-Yan Zhong
The First Affiliated Hospital of Soochow University, China
|
时间 | 题目 | 讲者 | 单位 |
---|---|---|---|
10:00-10:08 |
DEB-TACE for advanced cervical cancer |
Jian-Fei Tu | Lishui Municipal Central Hospital, China |
10:08-10:16 |
Uterine artery embolization for adenomyosis: Evaluation of different embolization endpoints |
Yong Jin | The Second Affiliated Hospital of Soochow University, China |
10:16-10:24 |
A nomogram predicting venous thromboembolism risk in primary liver cancer patients |
Jing Xiao | Chongqing University Cancer Hospital, China |
10:24-10:32 |
Temporary covered stent placement with the aim of spontaneous migration for the treatment of bilioenteric anastomotic stricture |
Kun Yung Kim | Seoul National University Bundang Hospital, Korea |
10:32-10:40 |
Y-90 resin microspheres SIRT for liver cancer: A single-center experience |
Lei Zhang | Zhongda Hospiital, Southeast University, China |
10:40-10:48 |
Intestinal vascular malformations embolization or resection |
Xian-Chen Huang | The Fourth Affiliated Hospital of Soochow University, China |
10:48-11:00 |
Q & A |
时间 | 题目 | 讲者 | 单位 |
---|---|---|---|
11:00-11:08 |
DEB-TACE combined with thermal ablation versus DEB-TACE alone for large and multinodular HCC: Efficacy and prognostic factors analysis |
Lin Zheng | The Affiliated Cancer Hospital of Zhengzhou University,China |
11:08-11:16 |
Multimodal integration of radiology and pathology signatures for distinguishing between aldosterone-producing adenomas and nonfunctional adrenal adenomas |
Zhong-Zhi Jia | Changzhou Second People's Hospital, China |
11:16-11:24 |
Modified TACE using low-dose chemotherapy with blank microspheres plus low-dose lenvatinib and microwave ablation for large (≥7 cm) unresectable HCC: The TALEM trial |
Zhi-Mei Huang | Sun Yat-sen University Cancer Center, China |
11:24-11:32 |
Hepatic arterial infusion combined with lenvatinib plus tislelizumab for unresectable ICC: A retrospective cohort study |
Bang-Jian Zhou | The First Affiliated Hospital of Soochow University, China |
11:32-11:40 |
Calcium phosphate-stabilized vascular disrupting agents CA4P lipiodol emulsion for enhanced chemoembolization |
Lin-Zhu Zhang | Zhongda Hospiital, Southeast University, China |
11:40-12:00 |
Q & A |